th a high-risk profile.[@ytz242-B2]^,^[@ytz242-B14]

Conclusion
==========

Management of athletes presenting with cardiomyopathy and AF is often challenging. Expert opinion should be sought, and guidance should be individualized. Management options are aimed to minimize the risks to the athletes if they choose to return to competitive sports. It is reasonable to consider an LAAO device in athletes with AF and a risk profile that would normally warrant oral anticoagulation who are competing in contact sports.

Lead author biography
=====================

![](ytz242f5){#ytz242-F5}

Dr Andre Briosa e Gala graduated from Charles University of Prague in 2011. He completed his Foundation and Core Medical Training in the Oxford Deanery, attaining membership of the Royal College of Physicians (UK) in 2015. In 2016, in started his Cardiology training in the University Hospital of Southampton. He is currently an electrophysiology clinical research fellow in the Oxford University Hospitals with a research interest in atrial fibrillation.

Supplementary material
======================

[Supplementary material](#sup1){ref-type="supplementary-material"} is available at *European Heart Journal - Case Reports* online.

**Slide sets:** A fully edited slide set detailing this case and suitable for local presentation is available online as [Supplementary data](#sup1){ref-type="supplementary-material"}.

**Consent:** The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance.

**Conflict of interest:** none declared.

Supplementary Material
======================

###### 

Click here for additional data file.


1. Introduction {#sec1}
===============

Age-related macular degeneration (AMD) is the main cause of legal blindness (visual acuity lower than 20/200) in the Western world in people aged over 55 years \[[@B1]\]. It is a degenerative and progressive macular disease that results in loss of cent